A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly

Phase 1 Completed 20 enrolled Seoul National University Hospital

NaSingle-groupOpen-labelTreatment

Summary

A clinical study to evaluate pharmacokinetic, pharmacodynamic, and pharmacogenomic characteristics of Rosuvastatin in the elderly after multiple administration of Rosuvastatin

Timeline

Start: 2015-04
Primary completion: 2016-04
Completion: 2016-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rosuvastatin	Small molecule	20 mg	Oral

Indications

No indication recorded.